Tags

Type your tag names separated by a space and hit enter

Levodopa in the treatment of Parkinson's disease.
Prim Care. 1977 Sep; 4(3):541-60.PC

Abstract

Levodopa is at present the most effective treatment of Parkinson's disease. Its use in combination with a peripheral decarboxylase inhibitor prolongs the elevation of plasma levels and decreases the incidence of peripheral side effects. Severe psychiatric and neurologic side-effects may necessitate reduction or cessation of the drug.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

264229

Citation

Lloyd, K G.. "Levodopa in the Treatment of Parkinson's Disease." Primary Care, vol. 4, no. 3, 1977, pp. 541-60.
Lloyd KG. Levodopa in the treatment of Parkinson's disease. Prim Care. 1977;4(3):541-60.
Lloyd, K. G. (1977). Levodopa in the treatment of Parkinson's disease. Primary Care, 4(3), 541-60.
Lloyd KG. Levodopa in the Treatment of Parkinson's Disease. Prim Care. 1977;4(3):541-60. PubMed PMID: 264229.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Levodopa in the treatment of Parkinson's disease. A1 - Lloyd,K G, PY - 1977/9/1/pubmed PY - 1977/9/1/medline PY - 1977/9/1/entrez SP - 541 EP - 60 JF - Primary care JO - Prim Care VL - 4 IS - 3 N2 - Levodopa is at present the most effective treatment of Parkinson's disease. Its use in combination with a peripheral decarboxylase inhibitor prolongs the elevation of plasma levels and decreases the incidence of peripheral side effects. Severe psychiatric and neurologic side-effects may necessitate reduction or cessation of the drug. SN - 0095-4543 UR - https://www.unboundmedicine.com/medline/citation/264229/Levodopa_in_the_treatment_of_Parkinson's_disease_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.